Projected Impact of HCV Treatment on Near-Term Progression of Advanced Liver Disease in HCV-Infected Patients in a High Prevalence Birth Cohort

被引：0
|
作者：
Rubin, Jaime [1 ]
McGarry, Lisa [1 ]
Panchmatia, Hemangi [1 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷
关键词：
D O I：
10.14309/00000434-201210001-01433
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1433
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [41] Comparison of the severity of liver disease in HCV-non-HIV-infected patients and HCV-HIV co-infected patients prior to HCV-treatment in an urban area
    Rodriguez, M
    Rodriguez, JF
    GASTROENTEROLOGY, 2001, 120 (05) : A366 - A366
  • [42] Improve screening of HCV infection by targeting high prevalence aged groups: analysis of a cohort of HCV and HIV co-infected patients
    Brogueira, Pedro
    Costa, Ana
    Miranda, Ana
    Peres, Susana
    Baptista, Teresa
    Aldir, Isabel
    Antunes, Isabel
    Ventura, Fernando
    Borges, Fernando
    Mansinho, Kamal
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 75 - 76
  • [43] CC GENOTYPE OF rs12979860 IL28B MODERATES PROGRESSION OF LIVER FIBROSIS IN HCV-INFECTED PATIENTS
    Frankova, S.
    Bartakova, R.
    Jirsa, M.
    Hejda, V.
    Urbanek, P.
    Merta, D.
    Spicak, J.
    Trunecka, P.
    Sperl, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S186 - S186
  • [44] The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients
    Ibrahim, Marwa K.
    AbdElrahman, Mohamed
    El Din, Noha G. Bader
    Tawfik, Salwa
    Abd-Elsalam, Sherief
    Omran, Dalia
    Barakat, Amal Z.
    Farouk, Sally
    Elbatae, Hassan
    El Awady, Mostafa K.
    MICROBIAL PATHOGENESIS, 2022, 162
  • [45] Lower Rates Of Naturally Occurring Resistance-Associated Substitutions (RASs) In Hepatitis C Virus (HCV)-Infected Chronic Kidney Disease (CKD) Patients Than In HCV-Infected Patients With Only Liver Disease
    Gupta, Ekta
    Choudhary, Manish Chandra
    Upadhyay, Nimisha
    Singh, Gaurav
    Nayak, Suman Lata
    Kumar, Manoj
    Sarin, Shiv Kumar
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 3635 - 3640
  • [46] Alpha v beta 6 integrin is highly upregulated in experimental liver fibrosis and associated with liver fibrosis progression in HCV-infected patients.
    Patsenker, E
    Popov, Y
    Stickel, F
    Mayer, B
    Niedobitek, G
    Schuppan, D
    HEPATOLOGY, 2004, 40 (04) : 543A - 543A
  • [47] SEVERITY OF LIVER STEATOSIS AFFECTS PROGRESSION OF DISEASE IN MONOINFECTED PATIENTS BUT NOT IN HCV/HIV CO-INFECTED PATIENTS
    Rodriguez-Torres, Maribel
    Brau, Norbert
    Rodriguez-Orengo, Jose F.
    Ortiz-Lasanta, Grisell
    Segarra-Alonso, Omar
    Marxuach, Acisclo M.
    HEPATOLOGY, 2009, 50 (04) : 1060A - 1060A
  • [48] Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
    Priyo Sasongko
    Retrovirology, 3 (Suppl 1)
  • [49] Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
    Sasongko, Priyo
    RETROVIROLOGY, 2006, 3
  • [50] Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
    Charlton, Michael
    Everson, Gregory T.
    Flamm, Steven L.
    Kumar, Princy
    Landis, Charles
    Brown, Robert S., Jr.
    Fried, Michael W.
    Terrault, Norah A.
    O'Leary, Jacqueline G.
    Vargas, Hugo E.
    Kuo, Alexander
    Schiff, Eugene
    Sulkowski, Mark S.
    Gilroy, Richard
    Watt, Kymberly D.
    Brown, Kimberly
    Kwo, Paul
    Pungpapong, Surakit
    Korenblat, Kevin M.
    Muir, Andrew J.
    Teperman, Lewis
    Fontana, Robert J.
    Denning, Jill
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brandt-Sarif, Theo
    Pang, Phillip S.
    McHutchison, John G.
    Reddy, K. Rajender
    Afdhal, Nezam
    GASTROENTEROLOGY, 2015, 149 (03) : 649 - 659
12345